153. Acute encephalitis with refractory repetitive partial seizures Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 3 /  Drugs : 3 - (DrugBank : 2) / Drug target genes : 3 - Drug target pathways : 22

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Anakinra
   Beijing Childrens Hospital,Capital Medical University
      2026   -   ChiCTR2600126257   China
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
Standard medical treatment
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
Tocilizumab
   Beijing Childrens Hospital,Capital Medical University
      2026   -   ChiCTR2600126257   China
   Peking University First Hospital
      2024   Phase 4   ChiCTR2400085185   China
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States